109 results
Page 3 of 6
8-K
EX-99.2
fzma9hikphhttlqcjt1
30 Jul 21
BeiGene Announces Approval in Canada of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Mantle Cell Lymphoma
7:39am
8-K
EX-99.1
rgoci02gq5 rwgblkr3
24 Jun 21
China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hepatocellular Carcinoma
4:14pm
8-K
EX-99.3
z7gnx3rq
11 Jun 21
Other Events
4:23pm
8-K
nkcjoswrviuc
11 Jun 21
Other Events
4:23pm
8-K
EX-10.1
lbte3m5 sq4uy
8 Apr 21
BeiGene Announces First Commercial Manufacturing Approval for Its State-of-the-Art Biologics
4:15pm
8-K
EX-99.1
2cd0r4pv
11 Jan 21
Regulation FD Disclosure
7:01am
8-K
EX-1.1
vn4doj
2 Dec 20
BeiGene Launches Proposed Public Offering by Selling Shareholders
5:17pm
PRER14A
3tfyjrd
28 Sep 20
Preliminary revised proxy
4:05pm
8-K
uwpbdd4 kmp
1 Jun 20
Other Events
4:04pm
8-K
EX-99.1
n2su3kdgxx27d14
1 Jun 20
Other Events
4:04pm